Reuters
UK · 2 hrs ago
✦ 72✓ Factual
Revolution's pancreatic cancer drug doubles survival, boosts quality of life
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 15/100
ObjectivePartisan
Low partisan intensity — consistent with factual reporting✓ Fair headline
A pancreatic cancer drug developed by Revolution Medicines has demonstrated the ability to double survival rates and improve quality of life in clinical trials, according to a Reuters health report.
Revolution's pancreatic cancer drug doubles survival, boosts quality of life
Revolution's pancreatic cancer drug doubles survival, boosts quality of life Reuters
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!